| # | Drug | Count |
|---|---|---|
| 0 | CONJUGATED ESTROGENS | 6 |
| 1 | ESTROGENS, CONJUGATED | 6 |
| 2 | MEDROXYPROGESTERONE ACETATE | 6 |
| 3 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 4 |
| 4 | ESTRADIOL | 4 |
| 5 | LEVOTHYROXINE SODIUM | 4 |
| 6 | ASPIRIN | 3 |
| 7 | ASPIRIN 325 MG | 3 |
| 8 | ASPIRIN 81 MG | 3 |
| 9 | CALCIUM | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FENOPROFEN CALCIUM | 1 | 0.0204 |
| 1 | PROPARACAINE HYDROCHLORIDE | 1 | 0.0019 |
| 2 | TRANYLCYPROMINE SULFATE | 1 | 0.0012 |
| 3 | PALONOSETRON HYDROCHLORIDE | 1 | 0.0002 |
| 4 | TAMOXIFEN CITRATE | 1 | 0.0002 |
| 5 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 4 | 0.0002 |
| 6 | NABUMETONE | 1 | 0.0002 |
| 7 | BENZOYL PEROXIDE | 1 | 0.0001 |
| 8 | APREPITANT | 1 | 0.0001 |
| 9 | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 7 |
| 1 | HMG-CoA Reductase Inhibitor [EPC] | 4 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 4 |
| 3 | Aromatase Inhibitor [EPC] | 3 |
| 4 | Calcium [EPC] | 3 |
| 5 | Corticosteroid [EPC] | 3 |
| 6 | Microtubule Inhibitor [EPC] | 3 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 3 |
| 9 | Progestin [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 1 | Progesterone [EPC] | 2 | 0.0001 |
| 2 | Estrogen [EPC] | 7 | 0.0000 |
| 3 | Androgen [EPC] | 1 | 0.0000 |
| 4 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 5 | Aromatase Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Insulin [EPC] | 1 | 0.0000 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 8 | Calcium [EPC] | 3 | 0.0000 |
| 9 | Microtubule Inhibitor [EPC] | 3 | 0.0000 |